Association between sitagliptin adherence and self-monitoring of blood glucose.

about

Association between sitagliptin adherence and self-monitoring of blood glucose.

Item

http://www.wikidata.org/entity/Q36228968

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Association between sitagliptin adherence and self-monitoring of blood glucose.

@ast

Association between sitagliptin adherence and self-monitoring of blood glucose.

@en

type

Item

label

Association between sitagliptin adherence and self-monitoring of blood glucose.

@ast

Association between sitagliptin adherence and self-monitoring of blood glucose.

@en

prefLabel

Association between sitagliptin adherence and self-monitoring of blood glucose.

@ast

Association between sitagliptin adherence and self-monitoring of blood glucose.

@en

P1476

Association between sitagliptin adherence and self-monitoring of blood glucose.

@en

P2093

Andrew Paris

http://www.w3.org/2001/XMLSchema#string

Chris M Kozma

http://www.w3.org/2001/XMLSchema#string

Mehmet Daskiran

http://www.w3.org/2001/XMLSchema#string

Naunihal S Virdi

http://www.w3.org/2001/XMLSchema#string

Somesh Nigam

http://www.w3.org/2001/XMLSchema#string

William M Dickson

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Using drug claims data to assess the relationship of medication adherence with hospitalization and costs.

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.

Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.

Longitudinal study of new and prevalent use of self-monitoring of blood glucose.

Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.

P304

555-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/193229681200600310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228438307

http://www.w3.org/2001/XMLSchema#string

P698

22768886

http://www.w3.org/2001/XMLSchema#string

P921

glucose monitoring

P932

3440052

http://www.w3.org/2001/XMLSchema#string